Cargando…
Cytokine-Based Immunotherapy for Advanced Kidney Cancer: Past Results and Future Perspectives in the Era of Molecularly Targeted Agents
Until recently, immunotherapy has been the only therapeutic option available for patients with advanced kidney cancer, even though different choices were often made on the two sides of the Atlantic Ocean. The absence of alternatives made different immunotherapeutic approaches common practice, even w...
Autores principales: | Porta, Camillo, Paglino, Chiara, Imarisio, Ilaria, Bonomi, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
TheScientificWorldJOURNAL
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901142/ https://www.ncbi.nlm.nih.gov/pubmed/17619768 http://dx.doi.org/10.1100/tsw.2007.154 |
Ejemplares similares
-
Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?
por: Porta, Camillo, et al.
Publicado: (2011) -
Safety and treatment patterns of multikinase inhibitors in patients with metastatic renal cell carcinoma at a tertiary oncology center in Italy
por: Porta, Camillo, et al.
Publicado: (2011) -
Lingual metastasis from renal cell carcinoma: a case report and literature review
por: Ganini, Carlo, et al.
Publicado: (2012) -
Modifying sunitinib schedule in advanced kidney cancer patients: Reflections from the results of the renal EFFECT trial
por: Porta, Camillo, et al.
Publicado: (2012) -
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma
por: Porta, Camillo, et al.
Publicado: (2008)